Decreased erythrocyte penetration of pefloxacin in cirrhotic patients.
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D001798:Blood Proteins / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D015366:Pefloxacin; D011485:Protein Binding
D000890:Anti-Infective Agents; D001798:Blood Proteins; D015366:Pefloxacin; D009643:Norfloxacin